SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001683168-24-001674
Filing Date
2024-03-25
Accepted
2024-03-25 17:08:53
Documents
57
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO 1 coeptis_i10ka-123122.htm   iXBRL 10-K/A 1471018
2 CERTIFICATION coeptis_ex3101.htm EX-31.1 13255
3 CERTIFICATION coeptis_ex3102.htm EX-31.2 13297
4 CERTIFICATION coeptis_ex3201.htm EX-32.1 4816
5 CERTIFICATION coeptis_ex3202.htm EX-32.2 4716
  Complete submission text file 0001683168-24-001674.txt   6770250

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE coep-20221231.xsd EX-101.SCH 43945
7 XBRL CALCULATION FILE coep-20221231_cal.xml EX-101.CAL 49693
8 XBRL DEFINITION FILE coep-20221231_def.xml EX-101.DEF 188606
9 XBRL LABEL FILE coep-20221231_lab.xml EX-101.LAB 307137
10 XBRL PRESENTATION FILE coep-20221231_pre.xml EX-101.PRE 256302
60 EXTRACTED XBRL INSTANCE DOCUMENT coeptis_i10ka-123122_htm.xml XML 1129249
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Filer) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39669 | Film No.: 24780080
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)